MGMT and central nervous system cancer: For instance, changes (e.g., mutation and methylation) in the serum DNAs (ctDNAs), such as MGMT 7-9, EGFR 10, and PTEN 9, have been proven to be effective biomarkers of glioma and may have the potential for the diagnosis of glioma.